Markets:

Overview

News

Currencies

International

Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

2.490 -0.050 (-1.97%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lantern Pharma Inc. - Common Stock

< Previous 1 2 3 4 Next >

3 Penny Stocks to Buy as the AI Sector Transforms Every Industry in 2023 ↗

May 19, 2023

These AI penny stocks could potentially offer potent long-term value at tremendously attractive prices at this time

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗

May 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 27, 2023

Via Benzinga

Lantern Pharma's Earnings: A Preview ↗

March 17, 2023

Via Benzinga

Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate ↗

September 14, 2022

Via Benzinga

Recap: Lantern Pharma Q2 Earnings ↗

August 08, 2022

Lantern Pharma (NASDAQ:LTRN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

7 AI Penny Stocks That Could Skyrocket in 2023 ↗

February 21, 2023

AI penny stocks represent great potential and high returns, given the fact this technology is only beginning to pervade society.

Via InvestorPlace

Earnings Preview: Lantern Pharma ↗

November 04, 2022

Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Lantern Pharma...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 27, 2022

On Thursday, 111 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 12, 2022

Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million.

Via Benzinga

Treating Pediatric Cancer? How Lantern Pharma Hopes To Improve The Lives Of Pediatric Cancer Patients During Childhood Cancer Awareness Month ↗

September 15, 2022

Every September organizations have worked to raise awareness for childhood cancer by participating in childhood cancer awareness month.

Via Benzinga

Lantern Pharma's New Phase 2 Clinical Trial –Harmonic™ — Approved for Launch by the FDA ↗

July 19, 2022

When most people think of lung cancer, they often picture a smoker.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Via Benzinga

Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study ↗

July 14, 2022

The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with...

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Lantern Pharma Q1 Earnings ↗

May 03, 2022

Lantern Pharma (NASDAQ:LTRN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lantern Pharma missed estimated...

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Lantern Pharma Earnings Preview ↗

May 02, 2022

Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lantern...

Via Benzinga

Lantern Pharma: Q4 Earnings Insights ↗

March 10, 2022

Lantern Pharma (NASDAQ:LTRN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Outlook For Lantern Pharma ↗

March 09, 2022

Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Benzinga Announces This Week's All Access Guests ↗

January 27, 2022

Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 24, 2022

Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

Lantern Pharma's LP-184 Receives Rare Pediatric, Orphan Drug Tags For Rare Form Of Cancer ↗

January 24, 2022

The FDA has granted Rare Pediatric Disease and Orphan Drug Designations to Lantern Pharma Inc's (NASDAQ: LTRN) LP-184 for Atypical Teratoid Rhabdoid Tumor...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...

Via Benzinga

Earnings Scheduled For November 1, 2021 ↗

November 01, 2021

Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 07, 2021

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of their outstanding shares is at $417.9 million....

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.